CPRIT is participating in BIO 2019 this week in Philadelphia with over 16,000 attendees representing the biotech and pharma industry from around the world. We will be educating them on funding opportunities for CPRIT’s Product Development Research program which is currently accepting applications for our Company Relocation Awards, Texas Company Awards, and Seed Awards.
AUSTIN — The Cancer Prevention and Research Institute of Texas (CPRIT) today awarded 10 new academic research grants totaling over $31 million to recruit eminent cancer researchers to Texas.
"Twelve years ago, Texas made history with an unprecedented initiative to take on cancer. Texas is clearly showing that the investment and focus have been worth it. We are making enormous progress in advancing the understanding of cancer science, accelerating potential cures and prevention strategies, and transforming the cancer landscape in Texas."
Today, the Texas Senate Committee on Finance unanimously approved HJR 12 by a vote of 10-0. This vote now clears the way for the bill to be considered by the full Senate.
This week, the Texas House of Representatives approved House Joint Resolution (HJR) 12 and House Bill (HB) 39 both by Rep. John Zerwas.
This week, CPRIT Chief Scientific Officer James Willson, MD presented invited testimony to the Senate Transportation Committee on SB 2014 and SB 2015 by Senator Pat Fallon. In his testimony, Dr. Willson outlined progress made on Childhood Cancer through CPRIT-funded research.
Chris Cutrone
Senior Communications Specialist
Phone: 512-305-8483
Email: ccutrone@cprit.texas.gov
